Cerus Corp. (CERS)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$2.59+0.78%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · CERS
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | 233.8 | 201.3 | 186.8 | 188.3 | 159.5 | 114.2 | 93.8 | 76.1 | 51.3 | 39.3 | 34.2 | 36.4 | 39.7 | 36.8 | 33.0 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 51.3 | 39.3 | — | 36.4 | 39.7 | 36.8 | 33.0 |
| Cost of Revenues | — | — | — | — | — | — | 41.2 | 33.4 | 31.6 | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — | — | — | 16.9 | 10.8 | 15.2 | 17.1 | 16.1 | 12.1 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 82.3 | 80.9 | 75.9 | 75.5 | 83.3 | 81.3 | 67.0 | 66.2 | 56.8 | 52.6 | 49.0 | 46.0 | 37.7 | 30.0 | 25.7 | 23.1 |
| Operating Income | (1.6) | (8.7) | (14.2) | (30.1) | (34.1) | (48.9) | (58.3) | (66.2) | (55.0) | (57.5) | (61.4) | (61.1) | (44.5) | (28.3) | (17.3) | (15.9) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 8.3 | 8.9 | 8.4 | 5.8 | 4.9 | 3.7 | 6.1 | 4.0 | 3.0 | 2.4 | 1.7 | 0.6 | 0.3 | 0.6 | 1.0 |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | — |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | — | — | — | 0.6 | 0.3 | 0.6 | — |
| Other Non-Operating Income / Expenses | (4.8) | (6.6) | (6.5) | (7.3) | (8.3) | (5.1) | (1.2) | (4.8) | (2.3) | 0.8 | (1.3) | 1.5 | 5.9 | (14.8) | 1.6 | (0.9) |
| EBT, Incl. Unusual Items | (6.4) | (15.3) | (20.8) | (37.3) | (42.3) | (54.1) | (59.6) | (71.0) | (57.3) | (56.7) | (62.7) | (59.5) | (38.6) | (43.1) | (15.7) | — |
| Income Tax Expense | 0.4 | 0.4 | 0.2 | 0.3 | 0.5 | 0.3 | 0.3 | 0.3 | 0.2 | 3.9 | 0.2 | (3.7) | 0.2 | 0.2 | 0.2 | — |
| Net Income | ||||||||||||||||
| Minority Interest | (0.1) | (0.0) | (0.0) | (0.2) | (0.0) | (0.0) | — | — | — | — | — | — | — | — | — | — |
| Net Income | (6.8) | (15.6) | (20.9) | (37.5) | (42.8) | (54.4) | (59.9) | (71.2) | (57.6) | (60.6) | (62.9) | (55.9) | (38.8) | (43.3) | (15.9) | (17.0) |
| Per Share | ||||||||||||||||
| Basic EPS | (0.03) | (0.08) | (0.11) | (0.21) | (0.24) | (0.32) | (0.37) | — | (0.44) | (0.56) | (0.62) | (0.58) | (0.52) | (0.64) | (0.29) | (0.35) |
| Diluted EPS | (0.03) | (0.08) | (0.11) | (0.21) | (0.24) | (0.32) | (0.37) | — | (0.44) | (0.56) | (0.62) | (0.61) | (0.61) | (0.64) | (0.33) | (0.35) |
| Basic Weighted Avg Shares | 200.6 | 190.6 | 184.6 | 180.3 | 176.5 | 171.3 | 163.9 | 139.8 | 131.7 | 108.2 | 101.8 | 96.1 | 74.8 | 67.6 | 54.5 | 48.1 |
| Diluted Weighted Avg Shares | 200.6 | 190.6 | 184.6 | 180.3 | 176.5 | 171.3 | 163.9 | 139.8 | 131.7 | 108.2 | 101.8 | 96.9 | 76.5 | 67.6 | 55.1 | 48.1 |
| Supplemental | ||||||||||||||||
| EBITDA | — | (6.7) | (12.2) | (27.7) | (31.6) | (46.4) | (56.1) | (64.0) | (53.9) | (56.3) | (60.3) | (60.0) | (43.8) | (27.9) | (16.9) | (15.0) |
| EBIT | (1.6) | (8.7) | (14.2) | (30.1) | (34.1) | (48.9) | (58.3) | (66.2) | (55.0) | (57.5) | (61.4) | (61.1) | (44.5) | (28.3) | (17.3) | (15.9) |
| Effective Tax Rate | -6.1% | — | — | -0.9% | -1.2% | -0.6% | -0.5% | -0.4% | -0.4% | -6.9% | -0.3% | 6.2% | -0.5% | -0.5% | -1.5% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.